News Releases


25 November 2020
TORONTO , Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis








News Releases

25 November 2020
TORONTO , Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis
05 November 2020
Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance ™, in the U.S. market in partnership with Kristen Bell Cronos Israel received approval to sell PEACE NATURALS ™ branded pre-rolls and oils in Israel Cronos
14 October 2020
New CBD skincare collection redefines self-care TORONTO and LOS ANGELES , Oct. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced the launch of Happy Dance™, a new, clean, simple CBD skincare brand, co-founded with actress and
05 October 2020
TORONTO and GAN SHMUEL , Israel , Oct. 05, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) a global cannabinoid company, is pleased to announce the launch of its leading medical brand PEACE NATURALS™, in pharmacies throughout Israel through
15 September 2020
TORONTO , Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020 , the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020
06 August 2020
Cronos Israel commenced the sale of PEACE NATURALS™ products to the Israeli medical cannabis market Natuera completed three additional test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes Successfully implemented a new enterprise resource planning system
09 July 2020
TORONTO , July 09, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that, effective today, the Company has continued from the laws of the Province of Ontario to the laws of the Province of British Columbia (the “Continuance”).The
29 May 2020
TORONTO , May 29, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at two upcoming investor conferences: Piper Sandler 40th Annual
08 May 2020
Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel , as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS™   branded products Natuera completes key
30 March 2020
Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids
17 March 2020
TORONTO , March 17, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced today that the Company determined, on the recommendation of the Audit Committee of the Company’s Board of Directors and after consultation with KPMG LLP , the
02 March 2020
TORONTO , March 02, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission , providing the Company a 15-day extension of the due date for filing its
07 January 2020
TORONTO , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the ICR Conference 2020 on January 14, 2020 at 9:00 a.m.